User profiles for C. Tovar

Camilo E. Tovar

- Verified email at imf.org - Cited by 2935

Carolina Tovar Ingar

- Verified email at lamolina.edu.pe - Cited by 2034

[HTML][HTML] DSGE models and central banks

CE Tovar - Economics, 2009 - degruyter.com
Over the past 15 years there has been remarkable progress in the specification and estimation
of dynamic stochastic general equilibrium (DSGE) models. Central banks in developed …

The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer

EP Murchison, C Tovar, A Hsu, HS Bender… - Science, 2010 - science.org
The Tasmanian devil, a marsupial carnivore, is endangered because of the emergence of a
transmissible cancer known as devil facial tumor disease (DFTD). This fatal cancer is …

Understanding climate change impacts on biome and plant distributions in the Andes: Challenges and opportunities

C Tovar, AF Carril, AG Gutiérrez… - Journal of …, 2022 - Wiley Online Library
Aim Climate change is expected to impact mountain biodiversity by shifting species ranges
and the biomes they shape. The extent and regional variation in these impacts are still poorly …

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

C Tovar, J Rosinski, Z Filipovic… - Proceedings of the …, 2006 - National Acad Sciences
The p53 tumor suppressor retains its wild-type conformation and transcriptional activity in
half of all human tumors, and its activation may offer a therapeutic benefit. However, p53 …

Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1

LT Vassilev, C Tovar, S Chen… - Proceedings of the …, 2006 - National Acad Sciences
CDK1 is a nonredundant cyclin-dependent kinase (CDK) with an essential role in mitosis,
but its multiple functions still are poorly understood at a molecular level. Here we identify a …

Stapled α− helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy

…, B Graves, V Guerlavais, C Tovar… - Proceedings of the …, 2013 - National Acad Sciences
… − T 0 )/(CC 0 )], in which T and C represent mean tumor volume on a specific day during
the experiment of a treated group and the vehicle control group, respectively, and T 0 and C 0 …

[HTML][HTML] The challenge of unprecedented floods and droughts in risk management

…, W Szalińska, Q Tang, F Tian, T Tokarczyk, C Tovar… - Nature, 2022 - nature.com
Risk management has reduced vulnerability to floods and droughts globally 1 , 2 , yet their
impacts are still increasing 3 . An improved understanding of the causes of changing impacts …

Discovery of RG7388, a potent and selective p53–MDM2 inhibitor in clinical development

…, F Podlaski, C Janson, C Tovar… - Journal of medicinal …, 2013 - ACS Publications
Restoration of p53 activity by inhibition of the p53–MDM2 interaction has been considered
an attractive approach for cancer treatment. However, the hydrophobic protein–protein …

Endogenous repair after spinal cord contusion injuries in the rat

MS Beattie, JC Bresnahan, J Komon, CA Tovar… - Experimental …, 1997 - Elsevier
… A fascicle of axons (block arrow, C) is next to several macrophages (open block arrows, C).
The macrophages in D are from the lesion center at 5 days and contain many more dense …

Discovery of RG7112: a small-molecule MDM2 inhibitor in clinical development

…, JJ Liu, C Zhao, K Glenn, Y Wen, C Tovar… - ACS medicinal …, 2013 - ACS Publications
The p53 tumor suppressor is a potent transcription factor that plays a key role in the regulation
of cellular responses to stress. It is controlled by its negative regulator MDM2, which binds …